Search research articles
Contact Us
Filters
Showing results (51-60 of 66) with videos related to
Page
of 7
Sort By:
The International Journal of Neuropsychopharmacology
|
September 5, 2020
Clinical Correlates and Outcome of Major Depressive Disorder and Comorbid Migraine: A Report of the European Group for the Study of Resistant Depression
Gernot Fugger, Markus Dold, Lucie Bartova, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
February 20, 2021
Melancholic features in major depression - a European multicenter study
Markus Dold, Lucie Bartova, Gernot Fugger, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
November 26, 2021
Evidence on sociodemographic and clinical correlates of antidepressant combination or augmentation with second-generation antipsychotics in major depressive disorder
Gernot Fugger, Lucie Bartova, Markus Dold, et al.
The International Journal of Neuropsychopharmacology
|
October 12, 2021
The Choice of Either Quetiapine or Aripiprazole as Augmentation Treatment in a European Naturalistic Sample of Patients With Major Depressive Disorder
Lucie Bartova, Gernot Fugger, Markus Dold, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
October 13, 2020
Add-on benzodiazepine treatment in patients with major depressive disorder - results from a European cross-sectional multicenter study
Markus Dold, Lucie Bartova, Gernot Fugger, et al.
Journal of Affective Disorders
|
June 12, 2022
The sociodemographic and clinical phenotype of European patients with major depressive disorder undergoing first-line antidepressant treatment with NaSSAs
Gernot Fugger, Lucie Bartova, Chiara Fabbri, et al.
The International Journal of Neuropsychopharmacology
|
June 4, 2018
Major Depression and the Degree of Suicidality: Results of the European Group for the Study of Resistant Depression (GSRD)
Markus Dold, Lucie Bartova, Gernot Fugger, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
January 6, 2022
The sociodemographic and clinical profile of patients with major depressive disorder receiving SSRIs as first-line antidepressant treatment in European countries
Gernot Fugger, Lucie Bartova, Chiara Fabbri, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
February 27, 2025
The role of esketamine in persistent long COVID with predominant psychiatric manifestations
Ina Bozic, Dominik Ivkic, Lutz Reinfried, et al.
Plos One
|
August 27, 2013
Discontinuous patterns of brain activation in the psychotherapy process of obsessive-compulsive disorder: converging results from repeated FMRI and daily self-reports
Günter Schiepek, Igor Tominschek, Stephan Heinzel, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 66) with videos related to
Sort By:
Page
of 7
The International Journal of Neuropsychopharmacology
|
September 5, 2020
Clinical Correlates and Outcome of Major Depressive Disorder and Comorbid Migraine: A Report of the European Group for the Study of Resistant Depression
Gernot Fugger, Markus Dold, Lucie Bartova, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
February 20, 2021
Melancholic features in major depression - a European multicenter study
Markus Dold, Lucie Bartova, Gernot Fugger, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
November 26, 2021
Evidence on sociodemographic and clinical correlates of antidepressant combination or augmentation with second-generation antipsychotics in major depressive disorder
Gernot Fugger, Lucie Bartova, Markus Dold, et al.
The International Journal of Neuropsychopharmacology
|
October 12, 2021
The Choice of Either Quetiapine or Aripiprazole as Augmentation Treatment in a European Naturalistic Sample of Patients With Major Depressive Disorder
Lucie Bartova, Gernot Fugger, Markus Dold, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
October 13, 2020
Add-on benzodiazepine treatment in patients with major depressive disorder - results from a European cross-sectional multicenter study
Markus Dold, Lucie Bartova, Gernot Fugger, et al.
Journal of Affective Disorders
|
June 12, 2022
The sociodemographic and clinical phenotype of European patients with major depressive disorder undergoing first-line antidepressant treatment with NaSSAs
Gernot Fugger, Lucie Bartova, Chiara Fabbri, et al.
The International Journal of Neuropsychopharmacology
|
June 4, 2018
Major Depression and the Degree of Suicidality: Results of the European Group for the Study of Resistant Depression (GSRD)
Markus Dold, Lucie Bartova, Gernot Fugger, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
January 6, 2022
The sociodemographic and clinical profile of patients with major depressive disorder receiving SSRIs as first-line antidepressant treatment in European countries
Gernot Fugger, Lucie Bartova, Chiara Fabbri, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
February 27, 2025
The role of esketamine in persistent long COVID with predominant psychiatric manifestations
Ina Bozic, Dominik Ivkic, Lutz Reinfried, et al.
Plos One
|
August 27, 2013
Discontinuous patterns of brain activation in the psychotherapy process of obsessive-compulsive disorder: converging results from repeated FMRI and daily self-reports
Günter Schiepek, Igor Tominschek, Stephan Heinzel, et al.
Page
of 7